Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

718
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
718
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Use of Deep Learning in RNA Therapeutic Development.

ACS nano·2026
Same author

Plug-and-play assembly of biodegradable ionizable lipids for potent mRNA delivery and gene editing in vivo.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Identification of 4,5,6,7-Tetrabromo-1<i>H</i>-benzotriazole (TBB) as a Small Molecule MESH1 Inhibitor that Suppresses Ferroptosis.

bioRxiv : the preprint server for biology·2026
Same author

TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug Delivery.

ACS nano·2025
Same author

Taking a deep dive with active learning for drug discovery.

Nature computational science·2024
Same author

Finding the most potent compounds using active learning on molecular pairs.

Beilstein journal of organic chemistry·2024
Same journal

Computing inspired by the brain: a journey from algorithms to organoids.

Nature computational science·2026
Same journal

Systematic bottom-up coarse-graining of hydrated excess proton transport across scales.

Nature computational science·2026
Same journal

Gaining biological insights through supervised data visualization.

Nature computational science·2026
Same journal

The inequalities of GPU access.

Nature computational science·2026
Same journal

Social technologies need societal alignment.

Nature computational science·2026
Same journal

The Quantum Optimization Benchmarking Library.

Nature computational science·2026
See all related articles

Related Experiment Video

Updated: Jul 2, 2025

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.3K

Characterizing emerging companies in computational drug development.

Chloe Markey1, Samuel Croset2, Olivia Ruth Woolley2

  • 1Department of Biomedical Engineering, Duke University, Durham, NC, USA.

Nature Computational Science
|February 27, 2024
PubMed
Summary
This summary is machine-generated.

Computational drug discovery is rapidly advancing, with many companies optimizing drug research and development pipelines. This analysis maps the competitive landscape, identifying high-risk and high-value opportunities in this complex industry.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K

Related Experiment Videos

Last Updated: Jul 2, 2025

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.3K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K

Area of Science:

  • Computational drug discovery
  • Artificial intelligence in pharmaceuticals
  • Drug development optimization

Background:

  • Drug research and development (R&D) is increasingly leveraging computational approaches.
  • A growing number of companies are specializing in algorithms, proprietary data, and hardware for distinct drug pipeline stages.

Purpose of the Study:

  • To comprehensively analyze companies in the computational drug discovery space.
  • To highlight industry trends, opportunities, and competitive dynamics.
  • To identify high-risk and high-value niches within the market.

Main Methods:

  • Industry analysis of companies in computational drug discovery.
  • Mapping of company strategies, specializations, and deals.
  • Identification of market trends and competitive positioning.

Main Results:

  • The computational drug discovery industry is highly complex and competitive.
  • Certain areas are densely occupied, indicating higher risk.
  • Underrepresented niches with high potential value were identified.

Conclusions:

  • Strategic analysis of the computational drug discovery market is crucial for identifying opportunities.
  • Understanding industry concentration and identifying underserved niches can guide investment and innovation.
  • Computational methods offer significant potential to accelerate and de-risk drug R&D.